Engaged Capital 13F, Q1 2024

Glenn Welling · quarter ending 31 March 2024 · filed 15 May 2024 · SEC CIK 1559771

$617.10M
Filed US book
11
Positions
17.3%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q1 2024

Weights are against the whole filed book. Changes are in shares held, against the Q4 2023 filing.

CompanyTickerValue% of bookvs Q4 2023
EVOLENT HEALTH INCEVH$106.94M17.3%unchanged
V F CORPVFC$81.94M13.3%unchanged
SHAKE SHACK INCSHAK$80.60M13.1%-43% shares
NCR VOYIX CORPORATIONVYX$73.71M11.9%+16% shares
UPBOUND GROUP INCUPBD$58.65M9.5%-31% shares
BRC INCBRCC$55.00M8.9%unchanged
NCR ATLEOS CORPORATIONNATL$49.56M8.0%unchanged
PRA GROUP INCPRAA$48.33M7.8%-8% shares
PORTILLOS INCPTLO$28.22M4.6%new
NEVRO CORP$27.23M4.4%-13% shares
ENVESTNET INC$6.92M1.1%new

What changed since Q4 2023

Against the Q4 2023 filing, Engaged Capital opened 2 new positions, added to 1, trimmed 4, left 4 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • PTLO$28.22M
  • ENVESTNET INC$6.92M

Exited

Nothing from the previous filing was sold outright.

Added to

Trimmed

  • SHAK-43%$80.60M
  • UPBD-31%$58.65M
  • PRAA-8%$48.33M
  • NEVRO CORP-13%$27.23M

Other quarters

Source: SEC Form 13F-HR, accession 0000921895-24-001205, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.